Plasma rich in growth factors (PRGF® – Endoret®) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts while inhibits and reverts TGF-{beta}1-induced myodifferentiation.
Invest Ophthalmol Vis Sci. 2011; 52(9):6066-73
Autores
Anitua E, Sanchez M, Merayo Lloves J, De la Fuente M, Muruzabal F, Orive G.
Autores
Anitua E, Sánchez M, Orive G.
The importance of understanding what is PRGF and what is not.
J Shoulder and Elbow Surgery 2011, 20, e23-e24
Autores
Anitua E, Sánchez M, Prado R, Orive G.
The P makes the difference in plasma rich in growth factors (PRGF) technology.
Platelets (In press 2011)
Autores
Anitua E, Alkhraisat MH, Orive G.
Perspectives and challenges in regenerative medicine using Plasma Rich in Growth Factors.
Journal of Controlled Release (In Press 2011)
Autores
Anitua E, Sánchez M, Orive G.
Potential of endogenous regenerative technology for in situ regenerative medicine.
Adv Drug Deliv Rev. 2010; 62 (7-8):741-52
Autores
Sanchéz M, Anitua E, Andia I.
Poor standardization in platelet-rich therapies hampers advancement.
Arthroscopy, 2010, 26 (6), 725-6
Autores
Anitua E, Sánchez M, Orive G, Andía I.
Delivering growth factors for therapeutics.
Trends Pharmacol Sci 2008;29:37-41
Autores
Alio J.L., Pastor S, Ruiz Colecha J, Rodriguez A, Artola A.
Treatment of ocular surface syndrome after LASIK with autologous platelet rich plasma.
J Refract Surg 2007; 23: 617-619
Autores
Germán A Rocha, Arantxa Acera, Juan A Durán
Laser in situ Keratomileusis Flap Necrosis After Trigeminal Nerve Palsy.
Arch Ophtalmol, 2007; 125 (10):1423-1425
Autores
Alio J, Abad M, Artola A, L. Rodriguez-Prats J, Pastor S, Ruiz-Colecha J
Use of Autologous Platelet-Rich Plasma in the Treatment of Dormant Corneal Ulcers.
Ophtalmology, 2007; 114 (7): 1286-1293
Autores
Alio J, Colecha J, Pastor S, Rodriguez A, Artola A.
Symptomatic Dry Eye Treatment with Autologous Platelet-Rich Plasma
Ophtalmic Res 2007; 39: 124-129
Autores
Anitua E, Sánchez M, Orive G, Andía I.
The potential impact of the preparation rich in growth factors (PRGF) in different medical fields.
Biomaterials 2007; 28: 4551-4560.
Autores
Anitua E, Sánchez M, Nurden AT, Nurden P, Orive G, Andía I.
New insights into and novel applications for platelet-rich fibrin therapies.
Trends Biotechnology 2006;5:227-234.
Autores
Márkez R, Montero I.
Subconjuntival application of regenerative factor rich plasma for the treatment of ocular alkali burns.
[ Ver Abstract ]Eur J Ophthalmol 2009; 19: 909-915